Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
    • For library administrators
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Journal of Cell Science
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Journal of Cell Science

  • Log in
Advanced search

RSS   Twitter  Facebook   YouTube  

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
    • For library administrators
Research Article
Rab10 regulates tubular endosome formation through KIF13A and KIF13B motors
Kan Etoh, Mitsunori Fukuda
Journal of Cell Science 2019 132: jcs226977 doi: 10.1242/jcs.226977 Published 19 February 2019
Kan Etoh
Laboratory of Membrane Trafficking Mechanisms, Department of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University, Aobayama, Aoba-ku, Sendai, Miyagi 980-8578, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsunori Fukuda
Laboratory of Membrane Trafficking Mechanisms, Department of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University, Aobayama, Aoba-ku, Sendai, Miyagi 980-8578, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mitsunori Fukuda
  • For correspondence: nori@m.tohoku.ac.jp
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Tables

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Rab8 and Rab10 are mainly localized at tubular endosomes. (A) Schematic representation of the method used to screen for Rabs that are mainly localized at tubular endosomes. In the first step, a library of HeLaM cells stably expressing EGFP-tagged Rabs (Rab1A–Rab43) was analyzed for the presence of at least one EGFP-positive tubular structure >20 µm in length (blue bars in B). In the second step, EGFP–Rab-expressing HeLaM cells were immunostained with antibody against MICAL-L1 (a tubular endosome marker), and then PCCs for the relationship between EGFP-tagged Rabs and MICAL-L1 were calculated (orange bars in B). (B) Quantification of the results of the first step (A-1, blue bars) and the second step (A-2, orange bars). The red line represents quadruple the median PCC value, and it was used as a threshold for tubular endosome localization of Rabs. (C) Colocalization between Rab8A/B (green, upper panels) or Rab10 (green, lower panels) and MICAL-L1 (magenta) at the endogenous protein level. The insets are magnified views of the boxed areas. Scale bars: 20 µm. (D) Line plot profiles of the yellow arrows in the insets in C. (E) Localization of EGFP–Rab10 (green), internalized Alexa-Fluor-594-conjugated Tf (Tf-Alexa594; magenta) and internalized anti-CD147 antibody (cyan) in HeLaM cells. HeLaM cells stably expressing EGFP–Rab10 were incubated for 2 h at 37°C with both Tf-Alexa594 (5 μg/ml) and anti-CD147 antibody (5 μg/ml). The insets are magnified views of the boxed areas. Scale bar: 20 µm. (F) Line plot profiles of the yellow arrows in the insets in E.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Rab10, but not Rab8, is essential for tubular endosome formation. (A,B) Rab8-DKO and Rab10-KO HeLaM cells generated by the CRISPR/Cas9 system. Cell lysates of parental cells (WT), Rab8-DKO cells, Rab8-DKO cells stably expressing Myc-tagged Rab8A (Rab8-DKO+Myc–Rab8A) cells (A), Rab10-KO cells and Rab10-KO cells stably expressing Rab10 (Rab10-KO+Rab10) cells (B) were analyzed by immunoblotting (IB) with the antibodies indicated. (C,D) Tubular endosomes in Rab8-DKO cells (C) and Rab10-KO cells (D). Rab8-DKO cells and Rab8-DKO+Myc–Rab8A cells stably expressing EGFP–Rab10 were immunostained with anti-Rab8 antibody (C). Rab10-KO cells and Rab10-KO+Rab10 cells were immunostained with antibodies against Rab8 and MICAL-L1 (D). The insets are magnified views of the boxed areas. Scale bars: 20 µm. (E) Quantification of the percentage of cells containing at least one EGFP–Rab10 tubule >20 µm in length. (F) Quantification of the percentage of cells containing at least one Rab8 tubule >20 µm in length. (G) Quantification of the percentage of cells containing at least one MICAL-L1-tubule >20 µm in length. The bars represent the mean±s.e.m. of data from three independent experiments (n=3; more than 20 cells were analyzed in each experiment). **P<0.01; N.S., not significant (unpaired two-tailed Student's t-test). (H) Histogram analysis of the length of MICAL-L1-positive tubules in Rab10-KO cells and Rab10-KO+Rab10 cells. Total tubule length (i.e. the sum of the length of all tubules) in individual cells was classified into five categories: <5 µm, 5–20 µm, 20–50 µm, 50–100 µm or >100 µm, and the number of cells containing tubules having the total tubule length in each category was counted as described in the Materials and Methods. The numbers of cells in each category as a percentage of the total cell population are expressed as stacked bar graphs. The bars represent the mean±s.e.m. of data from three independent experiments (n=3; more than 30 cells were analyzed in each experiment). ***P<0.001 (Pearson's χ2 test).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Microtubules are necessary for tubular endosome extension. (A) Dynamics of EGFP–Rab10-positive tubules. HeLaM cells stably expressing EGFP–Rab10 were analyzed by live-cell imaging on a spinning-disk confocal microscope. Image stacks of the regions of interest were captured, and maximum intensity projections were obtained. The time-lapse images of the boxed area captured at 4.8 s intervals are shown on the right. Arrowheads point to the fission sites of tubular endosomes. Scale bars: 20 µm (main image) and 2 µm (inset). (B) Effect of DMSO (control), cytochalasin D and nocodazole on EGFP–Rab10-positive tubules. HeLaM cells stably expressing EGFP–Rab10 were treated for 1 h with 0.1% DMSO, 10 µM cytochalasin D or 10 µg/ml nocodazole. The insets are magnified views of the boxed areas. Scale bar: 20 µm. (C) Percentage of cells containing EGFP–Rab10-positive tubules as shown in B. The bars represent the mean±s.e.m. of data from three independent experiments (n=3; more than 20 cells were analyzed in each experiment). *P<0.05; ***P<0.001 (Dunnett's test). (D) Colocalization between EGFP–Rab10 and mStr–EMTB (a microtubule marker). Typical images of HeLaM cells stably co-expressing EGFP–Rab10 and mStr–EMTB were captured with a conventional confocal microscope (upper panels) or OSR (Olympus Super Resolution; lower panels). The super-resolution images correspond to the boxed area in the upper right panel. The insets in the lower panels are magnified views of the boxed areas. Arrowheads point to a microtubule and EGFP–Rab10 double-positive tubule. Scale bar: 20 µm.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    KIF13A/B are novel Rab10-interacting proteins. (A) Schematic representation of mouse KIF13A/B. Amino acid (aa) numbers are shown on both sides of each KIF13 protein. The Rab10-binding homology domain (RHD) of KIF13A/B determined in this study is represented by orange lines. (B) Sequence alignment and predicted secondary structure of the RBD or RHD of mouse KIF13A/B, EHBP1 and MICAL1. The amino acid residues that are conserved and that are similar in more than three sequences are shown against a black background and against a shaded background, respectively. The predicted secondary structure is indicated above the corresponding sequences. (C) A 3D-homology model of the KIF13A RHD and the crystal structure of the Rab10–MICAL1 (RBD) complex (PDB 5LPN). The predicted 3D-structure of the KIF13A RHD (orange) is superimposed on the MICAL1 RBD (blue) in complex with Rab10 (silver). The α-helix 1 and α-helix 2 in the KIF13A RHD of the boxed area correspond to the secondary structure shown in B. (D) Schematic representation of KIF13A/B-tail mutants without a motor domain. (E) Interaction between Rab10 and KIF13A/B-tail. mStr–Rab10 and EGFP–KIF13A/B-tail were co-expressed in COS-7 cells, and their associations were analyzed by co-immunoprecipitation assays with glutathione–Sepharose beads coupled with GST–GFP nanobody, followed by immunoblotting with the antibodies indicated.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    The RHD of KIF13 is required for its localization at EGFP–Rab10-positive tubules. (A) Localization of Myc–KIF13A (WT and ΔRHD). HeLaM cells stably co-expressing EGFP–Rab10 (green) and Myc–KIF13A (WT or ΔRHD; magenta) were examined. The insets are magnified views of the boxed areas. Scale bars: 20 µm. (B) Line plot profiles of the yellow arrows in the insets in A. (C) Schematic representation of a KIF13A(ΔRHD) mutant that lacks an RHD, shown in orange. (D) PCCs for the relationship between EGFP–Rab10 and Myc–KIF13A (WT or ΔRHD) as shown in A. The bars represent the mean±s.e.m. of data from three independent experiments (n=3; more than five images were analyzed in each experiment). *P<0.05 (unpaired two-tailed Student's t-test). (E) Localization of Myc–KIF13A in Rab10-KO cells. Rab10-KO cells stably expressing Myc–KIF13A (green) were immunostained with the anti-MICAL-L1 antibody. The insets are magnified views of the boxed areas. Scale bars: 20 µm. (F) Percentage of cells containing at least one Myc–KIF13A-positive tubule >20 µm in length as shown in E. The bars represent the mean±s.e.m. of data from three independent experiments (n=3; more than 20 cells were analyzed in each experiment). *P<0.05 (unpaired two-tailed Student's t-test). (G) Unaltered expression of KIF13A/B in Rab10-KO cells. Cell lysates of parental (WT) cells, Rab10-KO cells and Rab10-KO cells stably expressing Rab10 (Rab10-KO+Rab10) were analyzed by immunoblotting (IB) with the antibodies indicated.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Both the motor domain and the RHD of KIF13A are necessary for tubular endosome formation. (A) KIF13A-KO, KIF13B-KO and KIF13-DKO HeLaM cells generated by the CRISPR/Cas9 system. Cell lysates of parental (WT), KIF13A-KO, KIF13B-KO and KIF13-DKO cells were analyzed by immunoblotting with the antibodies indicated. (B) Tubular endosomes in KIF13A-KO, KIF13B-KO and KIF13-DKO cells. Each cell line was immunostained with anti-MICAL-L1 antibody. The insets are magnified views of the boxed areas. Scale bar: 20 µm. (C) Percentage of cells containing at least one MICAL-L1-positive tubule >20 µm in length as shown in B. **P<0.01; ***P<0.001 (Dunnett's test). (D) Rescue of KIF13A-KO cells by exogenous expression of KIF13A mutants. KIF13A-KO cells stably co-expressing EGFP–Rab10 (green) and Myc–KIF13A (WT, ΔRHD or tail) (magenta) were tested. The insets are magnified views of the boxed areas. Scale bars: 20 µm. (E) Similar level of Myc–KIF13A expression (WT, ΔRHD or tail) in KIF13A-KO cells. Cell lysates of parental (WT) cells, KIF13A-KO cells and KIF13A-KO cells stably expressing Myc–KIF13A (WT, ΔRHD or tail) were analyzed by immunoblotting with the antibodies indicated. (F) Percentage of cells containing at least one EGFP–Rab10-positive tubule >20 µm in length as shown in D. The bars represent the mean±s.e.m. of data from three independent experiments (n=3; more than 20 cells were analyzed in each experiment). ***P<0.001 (one-way analysis of variance followed by the Tukey–Kramer test).

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Proposed model of the role of Rabs in tubular endosome formation. (A) In HeLaM cells, Rab10 is localized at endosomes and recruits KIF13 motors to induce endosome tubulation by pulling along a microtubule track. (B) Proposed model of Rab-mediated tubular endosome formation based on the results obtained in the present study together with previous reports (see Discussion for details). In the first step, CIE cargoes, including CD147, are internalized through an Arf6-dependent pathway (Eyster et al., 2009), and Rab13 and Rab35 may be involved in this step through actin reorganization (Chaineau et al., 2013; Sakane et al., 2012). In the second step, the internalized vesicle-to-tubular endosome transition occurs (Radhakrishna and Donaldson, 1997). Rab10 and Rab22A/B are necessary to complete this step, and thus KO of either Rab10 or Rab22A/B caused failure of tubular endosomes to develop. Rab5A and Rab21, neither of which colocalized with MICAL-L1, may not be directly involved in CIE cargo sorting/transport (Gong et al., 2007; Sabharanjak et al., 2002). In the final step, the CIE cargoes in the tubular endosome are sorted and transported into the PM, RE or TGN (step 3) (Hattula et al., 2006; Sabharanjak et al., 2002). Rab8, Rab11A and Rab17 may contribute to this step (Nakajo et al., 2016; Solis et al., 2013; Zacchi et al., 1998).

Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

Keywords

  • Rab10
  • Membrane trafficking
  • Organelle biogenesis
  • Small GTPase Rab
  • Tubular endosome

 Download PDF

Email

Thank you for your interest in spreading the word on Journal of Cell Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rab10 regulates tubular endosome formation through KIF13A and KIF13B motors
(Your Name) has sent you a message from Journal of Cell Science
(Your Name) thought you would like to see the Journal of Cell Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
Rab10 regulates tubular endosome formation through KIF13A and KIF13B motors
Kan Etoh, Mitsunori Fukuda
Journal of Cell Science 2019 132: jcs226977 doi: 10.1242/jcs.226977 Published 19 February 2019
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
Rab10 regulates tubular endosome formation through KIF13A and KIF13B motors
Kan Etoh, Mitsunori Fukuda
Journal of Cell Science 2019 132: jcs226977 doi: 10.1242/jcs.226977 Published 19 February 2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • Acknowledgements
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • An SNX10-dependent mechanism down-regulates fusion between mature osteoclasts
  • Combined heterogeneity in cell size and deformability promotes cancer invasiveness
  • Non-canonical ago loading of EV-derived exogenous single stranded miRNA in recipient cells
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

Follow us on Instagram

Cell science is bursting with beautiful images and over on Instagram, we’re showing them off! Find both JCS and FocalPlane on Instagram for stories and techniques across cell biology.


An interview with Derek Walsh

Professor Derek Walsh is the guest editor of our new special issue Cell Biology of Host-Pathogen Interactions. In an interview, Derek tells us about his work in the field of DNA viruses, the impact of the pandemic on virology and what his role as Guest Editor taught him.


How to improve your scientific writing

"If you are a scientist and you want to succeed, you must become a writer."

How do scientists become master storytellers? We called on our journal Editors, proofreaders and contributors to our community sites for their advice on how to improve your scientific writing.


Meet the preLighters: Jennifer Ann Black

Following the theme of our latest special issue, postdoc Jennifer Ann Black studies replication stress and genome plasticity in Leishmania in Professor Luiz Tosi’s lab in Sao Paolo. We caught up with Jenn (virtually) to hear about her relocation to Brazil mid-pandemic, her research on parasites and what she enjoys about ‘preLighting’.

In our special issue, Chandrakar et al. and Rosazza et al. present their latest work on Leishmania.


Mole – The Corona Files

“There are millions of people around the world who continue to believe that the Terrible Pandemic is a hoax.”

Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.


JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About Journal of Cell Science
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Fast-track manuscripts
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • JCS Prize
  • Manuscript transfer network
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contacts

  • Contact JCS
  • Subscriptions
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992